Following completion of my academic studies (PhD Immunology) at the University of Melbourne, I started work in the pharmaceutical industry. I have held a range of senior several medical, research and commercial positions covering a range of geographies and portfolios, and have worked in Australia, the UK and Italy. In 2008, I transferred to Belgium where GSK’s Vaccines Business is headquartered where I was Vice President of the Adult Vaccine Portfolio, leading the team that delivered successful management of the GSK Vaccines H1N1 pandemic and fostered the development of new quadrivalent flu and shingles vaccines. In 2012, I joined the corporate Government Affairs Public Policy & Patient Advocacy team where she led the negotiation of the first industry agreement to be signed with the WHO under the Pandemic Influenza Preparedness Framework whilst undertaking an MSc in Health Policy at the London School of Economics. My current role is heading the GSK-Save the Children Partnership which has the ambitious goal of helping to save the lives of 1 million children and I am also leading the Investment in Academia Initiative supporting GSK’s Africa and Developing Country Region 2020 strategy, as well as being the Global Head of GSK’s Access Medicines Portfolio.
Topics on my radar:
Base of the Pyramid, Education, Health, Inclusive Business Models, Partnerships, Social Enterprise, Women and Business
Other Topics on my radar:
SDGs, Maternal & Child Health, Child advocacy
No comments yet!
You need to be a member of Business Fights Poverty to add comments!